Cantor Fitzgerald maintains Ascendis Pharma Overweight rating
Cantor Fitzgerald reaffirmed its Overweight rating and $170.00 price target on Ascendis Pharma (NASDAQ:ASND) shares, currently trading at $119.49. The firm's analyst highlighted the early adoption of ...
US Senate panel advances Cantor Fitzgerald's Lutnick for Commerce Department chief
A U.S. Senate committee voted on Wednesday to advance President Donald Trump's nominee Howard Lutnick, billionaire chairman ...
Cantor Fitzgerald cuts Amgen stock target to $340 amid clinical hold
Cantor Fitzgerald adjusted its outlook on Amgen shares (NASDAQ:AMGN), reducing the price target from the previous $405.00 to $340.00. Despite the lowered price target, the firm maintained its ...
Trump Taps McKinsey CLO Pierre Gentin for Commerce Department GC
President Trump has nominated Pierre Gentin, chief legal officer of the consulting giant McKinsey & Co. since 2019, to serve ...